Blood Loss Clinical Trial
— AA+IVCOfficial title:
Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping Right Hepatic Resection for Large Hepatocellular Carcinoma: A Prospective Randomized Controlled Study
Verified date | August 2015 |
Source | Eastern Hepatobiliary Surgery Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ministry of Health |
Study type | Interventional |
Anterior approach results in better operative and survival outcomes compared with the
conventional approach in patients with large hepatocellular carcinoma (HCC), but anterior
approach has the problem of bleeding from the hepatic vein.
Our previous study showed that infrahepatic inferior vena cava (IVC) clamping can reduce
blood loss during conventional hepatic resection. The investigators guess infrahepatic IVC
clamping may also reduce blood loss in anterior approach right hepatic resection. So the
investigators conduct this prospective, randomized, controlled trial to compare anterior
approach combined with infrahepatic IVC clamping and anterior approach in major right
hepatectomy for large HCC.
Status | Enrolling by invitation |
Enrollment | 100 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Understanding and being willing to sign the informed consent form - Aged 18-75 years - Diagnosed HCC by clinical findings and radiography,tumor size = 5cm and located in the right lobe, need to perform right hemihepatectomy or major right hepatic resection (three Couinaud's segments) - Without any surgery contraindication - Child-Pugh grade A Exclusion Criteria: - Refusal to take part in the study - With lymph node or extrahepatic metastases - History of previous hepatectomy or other abdominal operation - Those who can not be follow-up - Non-HCC |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Eastern Hepatobiliary Surgery Hospital | The First Affiliated Hospital of Xiamen University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | intraoperative total blood loss | participants will be followed for the duration of the entire operation,an expected average of 140 minutes | Yes | |
Secondary | operation time | the duration of the entire operation,an expected average of 140 minutes | Yes | |
Secondary | intraoperative CVP value | participants will be followed for the duration of the parenchymal transection,an expected average of 20 minutes | Yes | |
Secondary | morbidity and mortality | participants will be followed for the duration of the postoperative hospital stay,an expected average of 15 days | Yes | |
Secondary | postoperative hepatorenal function | postoperative day 1,3 and 7 | Yes | |
Secondary | postoperative hospital stay | the duration of the postoperative hospital stay,an expected average of 15 days | Yes | |
Secondary | disease-free survival duration and overall survival duration | the duration from operation to recurrence or death,an expected average of 3 years | Yes | |
Secondary | blood loss during parenchymal transection | the duration of the parenchymal transection,an expected average of 20 minutes | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04588350 -
Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery
|
N/A | |
Completed |
NCT05426564 -
Exploratory Assessment of the Quantra® System in Adult ECMO Patients
|
||
Active, not recruiting |
NCT05492214 -
The Effect of Time Window for Umbilical Cord Clamping During Cesareans on Offspring Hemoglobin and Maternal Blood Loss
|
N/A | |
Withdrawn |
NCT05518279 -
Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures
|
Phase 3 | |
Enrolling by invitation |
NCT02910115 -
Cooling the Uterus in C-section After Dysfunctional Labor
|
N/A | |
Completed |
NCT02569658 -
Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty
|
N/A | |
Completed |
NCT01048658 -
Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures
|
Phase 4 | |
Terminated |
NCT02908516 -
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures
|
Phase 4 | |
Completed |
NCT04089865 -
Oral Versus Intravenous Tranexamic Acid
|
Phase 4 | |
Recruiting |
NCT06403163 -
Transfusion Surveillance in Anaesthesia
|
||
Recruiting |
NCT02265562 -
Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy
|
Phase 3 | |
Completed |
NCT02083809 -
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
|
N/A | |
Completed |
NCT02312440 -
Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty
|
Phase 3 | |
Completed |
NCT01895101 -
The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients
|
Phase 4 | |
Completed |
NCT01099475 -
Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery
|
N/A | |
Completed |
NCT00990288 -
The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery
|
Phase 4 | |
Completed |
NCT03365999 -
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
|
Phase 2 | |
Recruiting |
NCT05550623 -
Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation
|
N/A | |
Completed |
NCT05012202 -
Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women
|
||
Completed |
NCT02311309 -
Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery
|
N/A |